本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Mereo Biopharma Group Plc

0.2850
+0.00501.79%
盤前0.29360.0086+3.02%07:12 EDT
成交量:88.73萬
成交額:25.14萬
市值:4,535.25萬
市盈率:-1.63
高:0.2904
開:0.2800
低:0.2711
收:0.2800
52周最高:2.37
52周最低:0.2000
股本:1.59億
流通股本:1.31億
量比:0.41
換手率:0.68%
股息:- -
股息率:- -
每股收益(TTM):-0.1753
每股收益(LYR):-0.2627
淨資產收益率:-67.85%
總資產收益率:-42.46%
市淨率:1.58
市盈率(LYR):-1.08

資料載入中...

2019/05/21

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/05/21

員工持股計劃

Securities to be offered to employees in employee benefit plans
2019/05/21

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/05/08

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/05/07

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/05/07

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/05/03

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/05/03

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/05/01

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/04/30

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/04/30

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/04/30

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/04/29

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/04/29

年度報告

Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2019/04/26

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/04/24

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/04/23

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/03/15

企業合併公告

Prospectuses and communications, business combinations
2009/06/12

SEC問詢函

2009/06/12

[修訂]年度報告